What Is the
Difference Between Implantation of Cell Transplants of Human Versus Animal Origin

Precursor cell transplants can be manufactured for
clinical use from fetuses of any member of animal kingdom, from Homo
Sapiens to fish.

All cell transplants can be obtained
from animal sources.

While there has always been a shortage of human
organs, tissues and cells for transplantation, the cells, tissues and
organs, of animal origin have been abundant.

cell xeno-transplantation can be used
already today for treatment of thousands of sick people suffering from
diseases that cannot be cured or even treated by any other therapy. They
can be prepared in unlimited quantities, and ultimately at low cost.

Difficulties with procurement of human fetal material - ethical, moral, religious, psychological - that
ultimately lead to paucity of such material for cell transplantation,
have been, and will be, a continuous problem.

It has been, and will be, hard to develop
cell transplantation as a therapeutic method if there is enough material
to treat only a few patients: this situation has been slowing down
progress for many years.

Xeno-transplantation means the transplantation
of live cells, tissues, or organs between the species, in our case from
animals to humans, or reverse.

Allo-transplantation means a transplantation
within species, i.e. from a man to a man, or from horse to a horse, etc.

Here are some scientific facts that explain why
cell xeno-transplantation can be used instead of cell
allo-transplantation.

It has been known
already since 19th century, and the entire modern cell
biology is based on the fact, that all eukaryotic cells in Nature are
built and function according to the same laws.

In clinical practice of cell transplantation we have been dealing
with eukaryotic cells (of mammals) only.

Main cells of
the same organ or tissue are the same in Nature, (or nearly the same),
regardless of the species of origin.

It means that corresponding cells of the identical organ of different
animal species (including man) are biologically similar. The
hepatocyte, the main cell of liver, is almost the same in all
vertebrates, for example.

And we could make a similar statement about any of ~ 200 kinds of cells
of human or animal body. Scientists call this a 'principle of
organospecificity'.

There are no antigenic differences between the corresponding cells of
the identical organ of different animal species (including man).

This is another proof of 'organospecificity'.

All biological systems in Nature are composed of
the same types of molecules.

Great majority of proteins from different
organisms (including man) is
similar over the entire amino acid sequence, i.e. they are
homologous of each other,

and in general carry out similar functions.

Scientists call this a 'principle of
homology'.

The homologous proteins evolved over billions of
years from a common ancestor.

The basic law
of molecular biology, whereby DNA directs the synthesis of RNA, that
in turn directs the assembly of proteins, applies to all living
beings.

Genetic encoding is the same in most known organisms.

'Families' of similar genes encode proteins with similar functions. All
that implies that life on Earth evolved only once.

The described scientific data explain why it has
been possible to implant live cell transplants prepared from fetuses
of sheep,
cattle, pigs, horses, rabbits, and probably other mammals,

in ~ 5 million patients over the past 80+ years,
without any fatality or other serious consequences for individual patients or mankind.

Our company has always manufactured cell
transplants from rabbit fetuses (with the exception of cell
transplants of various endocrine glands, where newborn rabbits have been
the animal source; rabbitologists feel that there is no difference between
a rabbit fetus after completion of organogenesis and a newborn rabbit).

BCRO fetal precursor cell
transplantation, has been used successfully for 80+
years as treatment of many diseases

for which modern medicine has had no therapy
(i.e. incurable), or

in which 'state-of-art' therapies stopped being
effective (i.e. no longer treatable),

in documented over 5 millions of patients worldwide.
Physicians can learn about it in a textbook by E. Michael Molnar, M.D.:
Fetal Precursor Cell
Transplantation, BCRO Fetal Precursor Cell Transplantation", published
in 2014 by www.amazon.com
On
the same web site the general readership can find out all about it in
the book by the same author: Treatment of Incurable and No Longer
Treatable Diseases, published in January 2015, as well as in his
autobiography: Diseases and Genocide are
not Our Destiny. You can buy it as 'free reader download for PC' as
well as Kindle Book.